‘CORRUPTION': Dr. Mehmet Oz highlights the Medicaid fraud battle

• FDA approved Revolution Medicines' Rasonque for metastatic pancreatic cancer, nearly doubling median survival compared to standard chemotherapy.
• Moderna and Merck are developing an mRNA cancer vaccine for melanoma, lung, kidney, and liver cancers, aiming for FDA approval next year.
• CMS's Medicaid fraud war room stopped $203.3 million in potentially improper payments in 88 days, identifying 50 high-risk providers.
• The TrumpRx initiative, supported by 9 major Pharmacy Benefit Managers, has contributed to a 3.9% drop in prescription drug prices since President Trump took office, saving $700 million.

The discussion highlights significant advancements in healthcare, including the FDA approval of Revolution Medicines' Rasonque for pancreatic cancer and the development of an mRNA cancer vaccine by Moderna and Merck. It also covers CMS's successful crackdown on Medicaid fraud, recovering over $200 million, and the White House's TrumpRx initiative, which has led to a 3.9% drop in prescription drug prices.